Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.


CSE:PHRX - Post by User

Pharmadrug Inc > They laughed when LionWhisperer predicted 4 cents soon
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(15)
•••
Comment by SamRothsteinon Oct 12, 2021 9:48am
80 Views
Post# 33996805

RE:RE:They laughed when LionWhisperer predicted 4 cents soon

RE:RE:They laughed when LionWhisperer predicted 4 cents soonSure.  He had a 100% success rate.  That is so very believable.  If you have really bad fetal alchohol syndrome. And we all know how he got 27,000 likes.  He just had all his other fake nics like his posts.  You can't get that many likes honestly.  Just one of the many reasons he got the boot.  

PumpkinHeadSam wrote:
The legend Lion never missed a call as long as I have followed his posts and his blog...Thats why he was appraoching over 27ooo likes here on stockhouse as well......


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities